lymphoma alternating triple therapy (ATT) regimen in patients with stage IV indolent Fludarabine, mitoxantrone, dexamethasone (FND) compared with an

doi:10.1182/blood-2001-12-0269Prepublished online August 8, 2002;€€€€Ming Sheng Lee and Fernando CabanillasAndreas Sarris, Jorge Romaguera, Mark Hess, Terry L Smith, Ying Yang, Ana Ayala, Alejandro Preti, Apostolia M Tsimberidou, Peter McLaughlin, Anas Younes, Maria A Rodriguez, Fredrick B Hagemeister,€